This page has now closed. Please visit and follow Caidya for all updates! http://ow.ly/X80G50Lg5Ok
关于我们
Caidya is a multi-therapeutic clinical research organization (CRO) serving innovators worldwide. Focused on delivery excellence and an elevated customer experience, Caidya offers a wide range of clinical services and vast therapeutic expertise, supporting its partners from pre-IND strategy, through clinical development to submission and post-marketing surveillance. Caidya leverages industry-leading and proprietary clinical technology to ensure trial transparency and data-driven decision-making. Formed in 2021 following the merger of leading CROs, dMed and Clinipace, Caidya has nearly 1,800 employees in 30 countries throughout the world.
- 网站
-
https://www.caidya.com/
Clinipace的外部链接
- 所属行业
- 研究服务
- 规模
- 501-1,000 人
- 总部
- Morrisville，North Carolina
- 类型
- 私人持股
- 创立
- 2003
- 领域
- contract research organization、CRO、pharmaceuticals、medical devices、regulatory、clinical trials、biotechnology、clinical development、drug development、medical device development、data management和statistics
地点
Clinipace员工
-
Theresa Tafoya
Contract Manager at Clinipace Worldwide
-
Annette Hafer-McGee
Principal Clinical Trial Manager
-
Eric Grossman, MD
Adjunct Associate Professor of Medicine at NYU School of Medicine
-
David Focht
Independent Consultant of Technology Services/Data Management/Project Management/Business Analysis/Brand Development
动态
-
Hello Network! Caidya is searching for a VP, Rare Disease and Pediatrics to help enhance our strategic vision and drive operational excellence at our mid-sized, global CRO. Previous experience in the CRO industry is a required. This is a remote position anywhere in the U.S. If you're ready to lead and innovate in the field of rare disease, we invite you to apply and be part of our dynamic team!